Exchange Traded Concepts, LLC Ionis Pharmaceuticals Inc Transaction History
Exchange Traded Concepts, LLC
- $7.62 Billion
- Q2 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 8,802 shares of IONS stock, worth $374,525. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,802
Previous 3,244
171.33%
Holding current value
$374,525
Previous $97,000
257.73%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IONS
# of Institutions
404Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$697 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$688 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$526 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$439 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$358 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.04B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...